“…The antibodies against AvBD1, AvBD2, and CATH1 were used in our previous studies involving immunohistochemistry and western blot analysis ( Elhamouly et al, 2018 ; Elhamouly et al, 2019 ; Shimizu et al, 2020 ; Terada et al, 2020a ). Antisera against AvBD1, AvBD2, and CATH1 was raised by immunization of rabbits with keyhole limpet hemocyanin-conjugated synthetic peptide (anti-AvBD1 was obtained from Operon Biotechnologies K.K., Tokyo Japan; anti-AvBD2 was obtained from Medical & Biological Laboratories, Nagoya, Japan; and CATH1 was obtained from Sigma-Aldrich Japan K.K., Tokyo, Japan).…”